Keymed Biosciences Dividends and Buybacks
Dividend criteria checks 0/6
Keymed Biosciences does not have a record of paying a dividend.
Key information
n/a
Dividend yield
0.4%
Buyback Yield
| Total Shareholder Yield | 0.4% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Health Check: How Prudently Does Keymed Biosciences (HKG:2162) Use Debt?
Oct 21
There's Reason For Concern Over Keymed Biosciences Inc.'s (HKG:2162) Massive 28% Price Jump
May 13News Flash: 10 Analysts Think Keymed Biosciences Inc. (HKG:2162) Earnings Are Under Threat
Apr 03Keymed Biosciences Inc. (HKG:2162) Just Reported And Analysts Have Been Cutting Their Estimates
Mar 31A Look At The Intrinsic Value Of Keymed Biosciences Inc. (HKG:2162)
Nov 13Analysts Just Made A Noticeable Upgrade To Their Keymed Biosciences Inc. (HKG:2162) Forecasts
Sep 03Broker Revenue Forecasts For Keymed Biosciences Inc. (HKG:2162) Are Surging Higher
Mar 21Companies Like Keymed Biosciences (HKG:2162) Are In A Position To Invest In Growth
Jun 27Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 2162's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 2162's dividend payments have been increasing.
Dividend Yield vs Market
| Keymed Biosciences Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (2162) | n/a |
| Market Bottom 25% (HK) | 3.3% |
| Market Top 25% (HK) | 8.1% |
| Industry Average (Biotechs) | 1.1% |
| Analyst forecast (2162) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate 2162's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 2162's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate 2162's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 2162 has not reported any payouts.